This latest research builds upon the growing body of evidence demonstrating the unique impact of Brainomix's AI-powered software to expand access to life-changing stroke treatments across ...

International conference at CHIPS in Guntur emphasized AI's role in drug discovery, urging pharmacists to use technology effectively.

Gossamer Bio, Inc. , a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary ...

The SNU BioTalk 2025 an International Conference, themed "Symphony of Cellular Signals in Metabolism and Immune Response," ...

In the first term of the course, students made and programmed their own AI generators, which use artificial intelligence and ...

SAN DIEGO - Gossamer Bio, Inc. (NASDAQ:GOSS), a biopharmaceutical company in the clinical stage with a market capitalization of $225 million, has shared new research findings on its drug candidate ...

The event, scheduled from February 12-15 in Honolulu, will feature an oral presentation ... The final poster, presented by Dr. Aaron C. Logan, will focus on the impact of deep molecular remissions ...

As an international graduate student from Nigeria, Usman came to Quinnipiac with previous experience including his post as a ...

IT leaders are rapidly adopting automation and AI to fuel IT Service Management (ITSM) modernization initiatives. As demands for IT resources continue to rise, IT leaders are challenged to increase ...

The 2025 Design and Verification Conference and Exhibition (DVCon U.S.), sponsored by Accellera Systems Initiative, today announced its keynote speakers, a panel that will address if AI chips are ...

Unveiling the dark side of social media: fake content and artificial connections. Learn why authenticity is more important ...